These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11260085)

  • 21. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
    Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
    Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation.
    Oziel-Taieb S; Faucher-Barbey C; Chabannon C; Ladaique P; Saux P; Gouin F; Gastaut JA; Maraninchi D; Blaise D
    Bone Marrow Transplant; 1997 Jun; 19(11):1155-6. PubMed ID: 9193761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies.
    Chen Y; Wan X; Cao Y; Wang H; Han D; Zhang Y; Yao W; Song K; Fan Q; Zhu X; Sun Z; Liu H
    Blood Transfus; 2022 Mar; 20(2):156-167. PubMed ID: 34369864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation.
    Salmon JP; Michaux S; Hermanne JP; Baudoux E; Gérard C; Sontag-Thull D; Fillet G; Beguin Y
    Transfusion; 1999 Aug; 39(8):824-7. PubMed ID: 10504116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
    Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
    Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
    Wang Z; Sorror ML; Leisenring W; Schoch G; Maloney DG; Sandmaier BM; Storb R
    Br J Haematol; 2010 Apr; 149(1):101-10. PubMed ID: 20067562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report.
    Jaben EA; Jacob EK; Tauscher C; D'Souza A; Hogan WJ; Stubbs JR
    Transfusion; 2013 Jan; 53(1):202-5. PubMed ID: 22574682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation.
    Snell M; Chau C; Hendrix D; Fox R; Downes KA; Creger R; Meyerson H; Telen MJ; Laughlin MJ; Lazarus HM; Yomtovian R
    Bone Marrow Transplant; 2006 Jul; 38(2):135-40. PubMed ID: 16751785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation.
    Parkhideh S; Chegeni R; Mehdizadeh M; Roshandel E; Tavakoli F; Hajifathali A
    Transfus Apher Sci; 2020 Apr; 59(2):102696. PubMed ID: 31879058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical guide to ABO-incompatible allogeneic stem cell transplantation.
    Booth GS; Gehrie EA; Bolan CD; Savani BN
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1152-8. PubMed ID: 23571461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
    Quek J; Lee JJ; Lim FL; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh M; Loh Y; Linn YC
    Transfusion; 2019 Jan; 59(1):335-339. PubMed ID: 30467850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO incompatible stem cell transplantation in children does not influence outcome.
    Helming AM; Brand A; Wolterbeek R; van Tol MJ; Egeler RM; Ball LM
    Pediatr Blood Cancer; 2007 Sep; 49(3):313-7. PubMed ID: 16960869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.